United Bancshares Inc Asset Turnover Ratio (UPOH), as of third quarter 2019, current and historic results, rankings and more - CSIMarket
CSIMarket
 


United Bancshares Inc  (UPOH)
 

United Bancshares Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Sep 30 2019, United Bancshares Inc has not recorded any assets.
Visit United Bancshares Inc Balance sheet

Within sector 32 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2019 compared to the preceding quarter from to 3718.

Asset Turnover Ratio Definition



UPOH Asset Turnover Ratio (Sep 30 2019)
III. Quarter
(Mar 31 2019)
I. Quarter
(Sep 30 2015)
III. Quarter
(Jun 30 2015)
II. Quarter
(Mar 31 2015)
I. Quarter
Y / Y Asset Change -58.41 % -34.84 % -30.38 % -32.48 % -6.22 %
Y / Y Revenue Change - - - - 31.91 %
Asset Turnover Ratio (TTM) - - 0.06 0.04 0.02
UPOH's Total Ranking # 3718 # # # #
Seq. Asset Change -35.33 % -7.19 % -3.18 % -28.43 % 1.32 %
Seq. Revenue Change - - -9.39 % -11.93 % -



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 33
Healthcare Sector # 386
Overall Market # 3718

Asset Turnover Ratio Statistics
High Average Low
0.06 0.06 0.06
(Sep 30 2015)  







Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2019, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2019 Assets at quarter ending Sep 30 2019
Oxford Immunotec Global Plc  0.20 $ 48.611  Millions$ 238.607  Millions
Vaxart Inc   0.20 $ 7.713  Millions$ 37.870  Millions
Beone Medicines Ltd   0.20 $ 429.990  Millions$ 2,113.326  Millions
China Health Industries Holdings Inc   0.20 $ 9.187  Millions$ 45.162  Millions
Traws Pharma inc   0.20 $ 2.212  Millions$ 10.962  Millions
Aytu Biopharma Inc  0.20 $ 7.328  Millions$ 36.621  Millions
Journey Medical Corp  0.20 $ 82.873  Millions$ 422.351  Millions
Voyager Therapeutics Inc   0.20 $ 66.106  Millions$ 338.298  Millions
Acorda Therapeutics Inc   0.19 $ 223.301  Millions$ 1,152.745  Millions
Innovation1 Biotech Inc   0.19 $ 0.079  Millions$ 0.415  Millions
Adma Biologics Inc   0.19 $ 21.368  Millions$ 112.013  Millions
Remedent Inc   0.19 $ 1.375  Millions$ 7.221  Millions
Amicus Therapeutics inc   0.19 $ 159.588  Millions$ 838.745  Millions
Aerie Pharmaceuticals Inc   0.19 $ 59.687  Millions$ 315.361  Millions
Immunogen inc   0.18 $ 52.250  Millions$ 290.278  Millions
Vivani Medical Inc   0.18 $ 4.649  Millions$ 26.162  Millions
Clovis Oncology inc   0.18 $ 134.050  Millions$ 762.761  Millions
Fortress Biotech Inc   0.17 $ 34.490  Millions$ 197.596  Millions
Zymeworks Inc   0.17 $ 56.592  Millions$ 324.307  Millions
Therapeuticsmd Inc   0.17 $ 38.834  Millions$ 222.598  Millions
Capricor Therapeutics inc   0.17 $ 1.431  Millions$ 8.270  Millions
Adaptimmune Therapeutics Plc  0.17 $ 42.665  Millions$ 248.737  Millions
Nutriband Inc   0.17 $ 0.434  Millions$ 2.530  Millions
Fresh Tracks Therapeutics Inc   0.17 $ 7.372  Millions$ 43.214  Millions
Quotient Limited  0.17 $ 31.019  Millions$ 184.737  Millions
Decoy Therapeutics Inc   0.17 $ 1.657  Millions$ 10.042  Millions
Molecular Templates Inc   0.16 $ 20.757  Millions$ 126.268  Millions
Allergan plc  0.16 $ 15,817.600  Millions$ 97,428.375  Millions
Guardion Health Sciences Inc   0.16 $ 0.899  Millions$ 5.576  Millions
Cytokinetics Incorporated  0.16 $ 31.033  Millions$ 198.850  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.